Aardvark Therapeutics AARD
NASDAQ AARD
$4.42 +0.52 (+13.33%)
As of: Oct 21, 2026 · 11:41 AM EDT

Aardvark Therapeutics (AARD) Other financing activities (2024 - 2025)

Updated

Aardvark Therapeutics (AARD) posted Other financing activities of $1.19 million for FY2024.

Analysis

Aardvark Therapeutics (AARD) Other financing activities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Aardvark Therapeutics 95.03 Mn 21.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -77,000.00
Mar 31, 2025 -2.31 Mn
Dec 31, 2024 -1.18 Mn
Sep 30, 2024 -16,000.00
API Access

Aardvark Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AARD&period=max&api_key=YOUR_API_KEY